BR9306123A - Composição antiviral útil para o tratamento ou prevenção de uma infecção viral humana ou veterinária e processos de tratar ou prevenir uma infecção viral humana ou veterinária e doenças causadas por vírus papiloma humano hepatite C virus B da hepatite virus da varicela virus vaccinia ou construtos virais de vaccinia e citomegalovirus - Google Patents

Composição antiviral útil para o tratamento ou prevenção de uma infecção viral humana ou veterinária e processos de tratar ou prevenir uma infecção viral humana ou veterinária e doenças causadas por vírus papiloma humano hepatite C virus B da hepatite virus da varicela virus vaccinia ou construtos virais de vaccinia e citomegalovirus

Info

Publication number
BR9306123A
BR9306123A BR9306123A BR9306123A BR9306123A BR 9306123 A BR9306123 A BR 9306123A BR 9306123 A BR9306123 A BR 9306123A BR 9306123 A BR9306123 A BR 9306123A BR 9306123 A BR9306123 A BR 9306123A
Authority
BR
Brazil
Prior art keywords
virus
human
vaccinia
viral infection
hepatitis
Prior art date
Application number
BR9306123A
Other languages
English (en)
Portuguese (pt)
Inventor
Herbert A Blough
Original Assignee
Us Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/032,234 external-priority patent/US5491135A/en
Application filed by Us Bioscience filed Critical Us Bioscience
Publication of BR9306123A publication Critical patent/BR9306123A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9306123A 1992-03-18 1993-03-18 Composição antiviral útil para o tratamento ou prevenção de uma infecção viral humana ou veterinária e processos de tratar ou prevenir uma infecção viral humana ou veterinária e doenças causadas por vírus papiloma humano hepatite C virus B da hepatite virus da varicela virus vaccinia ou construtos virais de vaccinia e citomegalovirus BR9306123A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85345492A 1992-03-18 1992-03-18
US08/032,234 US5491135A (en) 1992-03-18 1993-03-17 Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
PCT/US1993/002432 WO1993018763A1 (fr) 1992-03-18 1993-03-18 Compositions d'acide n-(phosphonoacetyle)-l-aspartique (pala) et procedes d'utilisation de ces dernieres en tant que compositions antivirales a large spectre

Publications (1)

Publication Number Publication Date
BR9306123A true BR9306123A (pt) 1997-08-26

Family

ID=26708159

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9306123A BR9306123A (pt) 1992-03-18 1993-03-18 Composição antiviral útil para o tratamento ou prevenção de uma infecção viral humana ou veterinária e processos de tratar ou prevenir uma infecção viral humana ou veterinária e doenças causadas por vírus papiloma humano hepatite C virus B da hepatite virus da varicela virus vaccinia ou construtos virais de vaccinia e citomegalovirus

Country Status (10)

Country Link
EP (1) EP0660710A1 (fr)
JP (1) JPH07507770A (fr)
CN (1) CN1080853A (fr)
AU (1) AU3965993A (fr)
BR (1) BR9306123A (fr)
CA (1) CA2109435C (fr)
IL (1) IL105090A (fr)
IS (1) IS3987A (fr)
MX (1) MX9301527A (fr)
WO (1) WO1993018763A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
AU753336B2 (en) 1997-11-10 2002-10-17 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
WO1999040916A1 (fr) 1998-02-12 1999-08-19 G.D. Searle & Co. Utilisation de composes n-substitue-1,5-didesoxy-1,5-imino-d-glucitol dans le traitement des infections dues au virus de l'hepatite
WO2000047198A2 (fr) 1999-02-12 2000-08-17 G.D. Searle & Co. Utilisation de composes substitues 1,5-dideoxy-1,5-imino-d-glucitol pour traiter les infections par le virus de l'hepatite
CA2362785A1 (fr) 1999-02-12 2001-02-08 G.D. Searle & Co. Composes glucamine destines au traitement d'infections dues au virus de l'hepatite
WO2001045727A2 (fr) * 1999-12-20 2001-06-28 New Pharma Research Sweden Ab Compositions veterinaires
DE10138912A1 (de) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
CN111317733B (zh) * 2020-03-24 2022-07-12 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
WO2021189444A1 (fr) * 2020-03-24 2021-09-30 中国人民解放军海军军医大学 Utilisation d'antibiotiques du type rifamycine dans la préparation de médicaments contre des infections par le virus de la fièvre jaune
CN111419839A (zh) * 2020-03-31 2020-07-17 远见生物科技（上海）有限公司 利福霉素的新用途
US20230147364A1 (en) * 2020-04-30 2023-05-11 Kyoto University Prophylactic or therapeutic agent for rna virus-related diseases
EP4313150A1 (fr) * 2021-03-26 2024-02-07 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Combinaison d'inhibiteur de la biosynthèse de la pyrimidine destinée à être utilisée dans le traitement d'infections virales

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid

Also Published As

Publication number Publication date
JPH07507770A (ja) 1995-08-31
EP0660710A4 (fr) 1995-03-02
IL105090A0 (en) 1994-08-26
WO1993018763A1 (fr) 1993-09-30
MX9301527A (es) 1994-02-28
CN1080853A (zh) 1994-01-19
AU3965993A (en) 1993-10-21
EP0660710A1 (fr) 1995-07-05
CA2109435A1 (fr) 1993-09-19
CA2109435C (fr) 1997-03-11
IS3987A (is) 1993-09-19
IL105090A (en) 1998-08-16

Similar Documents

Publication Publication Date Title
BR9306123A (pt) Composição antiviral útil para o tratamento ou prevenção de uma infecção viral humana ou veterinária e processos de tratar ou prevenir uma infecção viral humana ou veterinária e doenças causadas por vírus papiloma humano hepatite C virus B da hepatite virus da varicela virus vaccinia ou construtos virais de vaccinia e citomegalovirus
FI904445A0 (fi) Antivirala foereningar.
EE9800382A (et) Lihtherpese viiruse ja teiste nakkushaiguste antimikroobne ravimenetlus
ITMI931522A1 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
ZM9387A1 (en) Treatment of diseases caused by viruses
DE68912155T2 (de) Antivirales Kombinationspräparat.
EP0289550A4 (fr) Vaccin utilise pour le traitement therapeutique de hsv.
EE9400068A (et) Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess
NO923824D0 (no) Bruk av trinitrobenzener eller karminsyre ved behandling av kreft eller virussykdommer
EP0382551A3 (en) Prevention and treatment of herpes virus infections
ATE208198T1 (de) Verwendung von aminopurinen antiviralen mitteln zur behandlung und prophylaxe der latenten herpes-virus infektionen
BR9916963A (pt) Bupropiona para tratamento de doenças virais
DK384387A (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
IL112183A0 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
IE892593L (en) Treatment of virus diseases
BR8404558A (pt) Tratamento de doencas causadas pelos virus do herpes
PT82258B (pt) Processo de preparacao de composicoes compreendendo interferao humano e nonilfenoxipolietanol para o tratamento de infeccoes virais por herpes simplex em humanos
SE9201942D0 (sv) Medel foer behandling eller foerebyggande av sjukdomstillstaand
LTIP170A (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
AR025145A1 (es) Derivados de tiourea que contienen diaminopiridina, composicion farmaceutica que los contienen, y el uso de dichos derivados para la manufactura de unmedicamento para tratar virus herpes
HU9200976D0 (en) Stabilized therapeutical preparative containing living virus, effective against viral and/or malign tumorous diseases and method for producing said preparative

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal